Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 2/20 | 0.49 |
| ▸ | CA1 | P00915 | 7/20 | 0.39 |
| ▸ | CA2 | P00918 | 7/20 | 0.39 |
| ▸ | CA9 | Q16790 | 7/20 | 0.39 |
| ▸ | GAA | P10253 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.37 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2594522 | 0.86 | MAOB (0.47) | MAOBCA1CA2CA9GAA | |
| SCHEMBL4900433 | 0.85 | GAA (0.48) | MAOBCA1CA2CA9GAA | |
| SCHEMBL8771887 | 0.85 | MAOB (0.37) | MAOBCA1CA2CA9GAA | |
| SCHEMBL1463813 | 0.84 | MAOB (0.48) | MAOBCA1CA2CA9GAA | |
| SCHEMBL1933227 | 0.84 | MAOB (0.48) | MAOBCA1CA2CA9GAA | |
| SCHEMBL2302250 | 0.84 | MAOB (0.48) | MAOBCA1CA2CA9GAA | |
| SCHEMBL30071045 | 0.81 | ALDH1A1 (0.50) | MAOBCA1CA2CA9GAA | |
| SCHEMBL9403390 | 0.80 | GNAI3 (0.52) | MAOBKMT2AMEN1MAPT | |
| SCHEMBL6258606 | 0.80 | GNAI3 (0.52) | MAOBKMT2AMEN1MAPT | |
| SCHEMBL6258210 | 0.80 | GNAI3 (0.52) | MAOBKMT2AMEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8454799-B2 | Pulp composition for paper and solid board production | BASF SE (DE) | 2013-06-04 | — | — | US | disclosed |
| EP-2567024-A1 | FIBROUS COMPOSITION FOR PAPER AND CARD PRODUCTION | BASF SE (DE) | 2013-03-13 | — | — | EP | disclosed |
| WO-2011138366-A1 | FIBROUS COMPOSITION FOR PAPER AND CARD PRODUCTION | BASF SE (DE) | 2011-11-10 | — | — | WO | disclosed |
| US-20080064899-A1 | Method For Producing Alpha, Beta-Unsaturated Carboxylic Acid | KAWATO SEIICHI | 2008-03-13 | — | — | US | disclosed |
| US-6710204-B2 | N-OXYL COMPOUND CONTAINED IN AN EASILY POLYMERIZABLE MATERIAL CAN BE SUFFICIENTLY DECREASED AND LOSS OF EASILY POLYMERIZABLE MATERIAL (ACRYLIC OR METHACRYLIC ACIDS OR THEIR ESTERS) IS LITTLE | MITSUBISHI RAYON CO., LTD. (JP) | 2004-03-23 | — | — | US | disclosed |
| US-20030078425-A1 | Decreasing method of N-oxyl compound | MITSUBISHI RAYON CO., LTD. (JP) | 2003-04-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030078425-A1 | Decreasing method of N-oxyl compound | NOC2L, LOXL2, VCL | MAOB 81/4885CA1 1210/4885CA2 2714/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.